← Back to Influence Map
Entity DossierOrganization
NATIONAL ASSOCIATION OF MANUFACTURERS
DC · US
Tracked direct giving
$0
Tracked donations to candidate
$0
LDA reported lobbying spend
$8,852,000
Connections
12
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
CAWClean Air/Water/Soil
$11.0MCHMChemicals/Chemical Industry
$11.0MCPTCopyright/Patent/Trademark
$11.0MCSPConsumer Protection
$11.0MENGENG
$11.0MENVEnvironment/Superfund
$11.0MFINFinancial Institutions/Investments
$11.0MFUEFuel/Gas/Oil
$11.0MGOVGovernment Issues
$11.0MHCRHealth Issues
$11.0MLobbying Firms Retained
NATIONAL ASSOCIATION OF MANUFACTURERS$11.0M
Bills Referenced in Lobbying Filings
march-inH.R. 8818
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| commented_on | Department of the Treasury | Public comment on TREAS-DO-2023-0009: U.S. Investments in Certain National Security Technologies and Products in Countries of Concern | Source |
| commented_on | Financial Crimes Enforcement Network | Public comment on FINCEN-2024-0005: Anti-Money Laundering Regulations for Residential Real Estate Transfers | Source |
| commented_on | Centers for Medicare & Medicaid Services | Public comment on CMS-2025-1889: Global Benchmark for Efficient Drug Pricing Model | Source |
| commented_on | Department of Energy | Public comment on DOE-HQ-2023-0050: Coordination of Federal Authorizations for Electric Transmission Facilities | Source |
| Lobbied for | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $1,500,000 | Source |
| Lobbied for | MARCH-IN Rights Proposal (NIH Framework) | LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $1,680,000 | Source |
| Lobbied for | American Privacy Rights Act (H.R.8818, 118th Congress) | LDA filing: lobbied on American Privacy Rights Act, period 2nd Quarter (Apr 1 - June 30), reported amount $1,850,000 | Source |
| Lobbied for | American Privacy Rights Act (H.R.8818, 118th Congress) | LDA filing: lobbied on American Privacy Rights Act, period 2nd Quarter (Apr 1 - June 30), reported amount $1,850,000 | Source |
| Lobbied for | Basel III Endgame Capital Rules (Fed/OCC/FDIC proposal) | LDA filing: lobbied on Basel III Endgame, period 1st Quarter (Jan 1 - Mar 31), reported amount $1,500,000 | Source |
| commented_on | Federal Trade Commission | Public comment on FTC-2023-0040: Premerger Notification; Reporting and Waiting Period Requirements | Source |
| Lobbied for | Rights to Federally Funded Inventions and Licensing of Government Owned Inventions | Lobbied on march-in — matched LDA filing topic to Federal Register rule. | Source |
| commented_on | Department of the Interior | Public comment on DOI-2017-0003: Regulatory Reform - Request for comments. | Source |